Related Experiment Videos
Dynamic evaluation of prolactin secretion during the early hours of life in human newborns
Insights
Newborns have normal pituitary prolactin (PRL) reserve, but may show immature pituitary dopaminergic receptors. Levodopa and pyridoxine failed to suppress PRL, while TRH increased it, indicating developmental differences.
Area of Science:
- Neonatal endocrinology
- Neuroendocrinology
- Pediatric physiology
Background:
- Prolactin (PRL) secretion regulation is complex.
- Understanding neonatal pituitary function is crucial for assessing endocrine health.
- Dopaminergic and thyrotropin-releasing hormone (TRH) pathways influence PRL release.
Purpose of the Study:
- To evaluate prolactin (PRL) secretion in human newborns.
- To assess the responsiveness of neonatal pituitary to dopaminergic and TRH stimulation.
- To investigate potential immaturity of pituitary receptors in early life.
Main Methods:
- Studied 30 human newborns in the early hours of life.
- Administered levodopa and pyridoxine to assess PRL suppression.
- Administered synthetic thyrotropin-releasing hormone (TRH) to assess PRL stimulation.
- Administered somatostatin to evaluate its effect on PRL levels.
Main Results:
- Levodopa and pyridoxine failed to suppress PRL release in all subjects.
- Synthetic TRH consistently induced a prompt increase in PRL levels.
- Somatostatin administration did not result in significant changes in PRL levels.
Conclusions:
- Neonatal pituitary exhibits normal PRL reserve.
- The lack of PRL suppression by levodopa and pyridoxine suggests potential immaturity of pituitary dopaminergic receptors in newborns.
- TRH effectively stimulates PRL release, indicating functional pathways.
Abstract:
PRL secretion was evaluated in 30 human newborns during the early hours of life. Both levodopa and pyridoxine administration failed to suppress PRL release in all subjects. Synthetic TRH elicited a constant, prompt increase in PRL levels. No significant changes were observed after somatostatin injections. These results demonstrate normal pituitary PRL reserve in newborns. The failure to respond to levodopa and pyridoxine administration might reflect partial immaturity of the pituitary dopaminergic receptors.